140 related articles for article (PubMed ID: 30015095)
1. HLA-G and anti-HCV in patients on the waiting list for kidney transplantation.
Sommese L; Paolillo R; Cacciatore F; Grimaldi V; Sabia C; Esposito A; Sorriento A; Iannone C; Rupealta N; Sarno G; Santangelo M; De Rosa P; Nicoletti G; Napoli C
Adv Med Sci; 2018 Sep; 63(2):317-322. PubMed ID: 30015095
[TBL] [Abstract][Full Text] [Related]
2. Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients.
Poláková K; Bandžuchová H; Žilinská Z; Chreňová S; Kuba D; Russ G
Immunobiology; 2015 Apr; 220(4):533-7. PubMed ID: 25468563
[TBL] [Abstract][Full Text] [Related]
3. Association of soluble human leukocyte antigen-G with acute tubular necrosis in kidney transplant recipients.
Krongvorakul J; Kantachuvesiri S; Ingsathit A; Rattanasiri S; Mongkolsuk T; Kitpoka P; Thammanichanond D
Asian Pac J Allergy Immunol; 2015 Jun; 33(2):117-22. PubMed ID: 26141032
[TBL] [Abstract][Full Text] [Related]
4. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
[TBL] [Abstract][Full Text] [Related]
5. Elevation of plasma soluble human leukocyte antigen-G in patients with chronic hepatitis C virus infection.
Weng PJ; Fu YM; Ding SX; Xu DP; Lin A; Yan WH
Hum Immunol; 2011 May; 72(5):406-11. PubMed ID: 21377504
[TBL] [Abstract][Full Text] [Related]
6. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
[TBL] [Abstract][Full Text] [Related]
7. Can Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List?
Bayraktar A; Akgül SU; Bakkaloğlu H; Temurhan S; Çınar ÇK; Çiftçi HŞ; Kaan Gök AF; Demir E; Oğuz FS; Türkmen A
Transplant Proc; 2020; 52(1):97-101. PubMed ID: 31901328
[TBL] [Abstract][Full Text] [Related]
8. Soluble human leukocyte antigen-G (SHLA-G) in Tunisian kidney transplantation.
Bardi R; Sfar I; Aounallah-Skhiri H; Kallala C; Abderrahim E; Ben Abdallah T; Gorgi Y
Arch Inst Pasteur Tunis; 2011; 88(1-4):42-6. PubMed ID: 23461142
[TBL] [Abstract][Full Text] [Related]
9. Circulating and renal expression of HLA-G prevented chronic renal allograft dysfunction in Japanese recipients.
Okushi Y; Okino K; Mukai K; Matsui Y; Hayashi N; Fujimoto K; Adachi H; Yamaya H; Yokoyama H
Clin Exp Nephrol; 2017 Oct; 21(5):932-940. PubMed ID: 28364323
[TBL] [Abstract][Full Text] [Related]
10. HLA-G expression in the peripheral blood of live kidney transplant recipients.
Xiao L; Zhou WQ; Shi BY; Feng K; He XY; Wei YX; Gao Y; Meng XY; Xiao W
Chin Med J (Engl); 2013 Jul; 126(14):2652-5. PubMed ID: 23876890
[TBL] [Abstract][Full Text] [Related]
11. The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance.
Hauer V; Risti M; Miranda BLM; da Silva JS; Cidral AL; Pozzi CM; Contieri FLC; Sadissou IA; Donadi EA; Augusto DG; Bicalho MDG
PLoS One; 2019; 14(2):e0212750. PubMed ID: 30794652
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
[TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant thrombomodulin therapy and soluble human leukocyte antigen-G levels during hematopoietic stem cell transplantation.
Nomura S; Ito T; Katayama Y; Ota S; Hayashi K; Fujita S; Satake A; Ishii K
Transpl Immunol; 2019 Apr; 53():28-33. PubMed ID: 30543860
[TBL] [Abstract][Full Text] [Related]
14. [Serum soluble HLA-G, soluble CD30 is correlated to the time after transplantation in renal transplant recipients].
Jin Z; Xu C; Duan W; Yang J; Tian P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul; 33(7):947-952. PubMed ID: 28712403
[TBL] [Abstract][Full Text] [Related]
15. Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-α and ribavirin treatment: potential role as markers of response to antiviral therapy.
Murdaca G; Contini P; Cagnati P; Marenco S; Pieri G; Lantieri F; Picciotto A; Puppo F
Clin Exp Med; 2017 Feb; 17(1):93-100. PubMed ID: 26567007
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Plasma Levels of Soluble HLA-G and HLA-G Genotypes in Kidney Transplant Recipients.
Piancatelli D; Maccarone D; Colanardi A; Sebastiani P; D'Anselmi F; Iesari S; Binda B; Pisani F
Transplant Proc; 2020 Jun; 52(5):1559-1561. PubMed ID: 32217007
[TBL] [Abstract][Full Text] [Related]
17. Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors.
Orandi BJ; Luo X; Massie AB; Garonzik-Wang JM; Lonze BE; Ahmed R; Van Arendonk KJ; Stegall MD; Jordan SC; Oberholzer J; Dunn TB; Ratner LE; Kapur S; Pelletier RP; Roberts JP; Melcher ML; Singh P; Sudan DL; Posner MP; El-Amm JM; Shapiro R; Cooper M; Lipkowitz GS; Rees MA; Marsh CL; Sankari BR; Gerber DA; Nelson PW; Wellen J; Bozorgzadeh A; Gaber AO; Montgomery RA; Segev DL
N Engl J Med; 2016 Mar; 374(10):940-50. PubMed ID: 26962729
[TBL] [Abstract][Full Text] [Related]
18. Transplantation Opportunities of Hepatitis C Virus-Seropositive Patients on the Kidney Waiting List.
Oruc A; Ersoy A
Transplant Proc; 2018 Dec; 50(10):3181-3184. PubMed ID: 29803528
[TBL] [Abstract][Full Text] [Related]
19. [Expression of human leucocyte antigen G in peripheral blood of kidney transplantation recipients].
Xiao L; Shi BY; Cai M; He XY; Xu XG; Han Y; Zhou WQ; Meng XY; Gao Y
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(4):241-4. PubMed ID: 20356537
[TBL] [Abstract][Full Text] [Related]
20. [Up-regulation of the sHLA-G5 level by human-mouse chimeric anti-IL-2R monoclonal antibody treatment in kidney transplantation].
Xiao L; Shi BY; Gao Y; He XY; Xu XG; Han Y; Zhou WQ; Meng XY; Han MX
Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(8):512-5. PubMed ID: 21418849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
